Cytokine production in hearts of Trypanosoma cruzi-infected CBA mice: Do cytokine patterns in chronic stage reflect the establishment of myocardial pathology?

Scandinavian Journal of Immunology

Volumn 44, Issue 5, 1996, Pages 421-429

  Sunnemark, D ^a   Ulfgren, A K ^b   Orn A ^a   Harris, R A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL INFILTRATION; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 0029842204     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-328.x     Document Type: Article

References (52)

1. Postan M, McDaniel JP, Dvorak JA. Studies of Trypanosoma cruzi clones in inbred mice. II. Course of infection of C57BL/6 mice with single-cell-isolated stocks. Am J Trop Med Hyg 1984;33:236-8.
2. Postan M, Cheevcr AW, Dvorak JA, McDaniel JP. A histopathological analysis of the course of myocarditis in C3H/He mice infected with Trypanosoma cruzi clone Sylvio-X10/4. Trans R Soc Trop Med Hyg 1986;80:50-5.
3. Postan M, Bailey JJ, Dvorak JA, McDaniel JP, Pottala EW. Studies of Trypanosoma cruzi clones in inbred mice. III. Histopathological and electrocardiographical responses to chronic infection. Am J Trop Med Hyg 1987;37:541-9.
4. Rossi MA, Goncalves S, Ribeiro-Dos-Santos R. Experimental Trypanosoma crzi cardiomyoputhy in Balb/c mice. Am J Pathol 1984;114:209-16.
5. Laucella S, Salcedo R, Castanos-Velez E et al. Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Parasite Immunology 1996;18:227-39.
6. Rottenberg ME, Sunnemark D, Leandersson T, Örn A. Organspecific regulation of interferon-gamma, interleukin-2 and interleukin-2 receptor during murine infection with Trypanosoma cruzi. Scand J Immunol 1993;37:559-68.
7. Leite de Moraes MD, Minoprio P, Dy M, Dardenne M, Savino W, Hontebeyrie-Joskowicz M. Endogenous IL-10 and IFN-gamma production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi. Scand J Immunol 1994;39:51-8.
8. Minoprio P, el Cheikh MC, Murphy E et al. Xid-associated resistance to experimental Chagas disease is IFN-gamma dependent. J Immunol 1993;151:4200-8.
9. Munoz-Fernandez MA, Fernandez MA, Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 1992;22:301-7.
10. Nabors G, Tarleton RL. Differential control of IFN-γ and IL-2 production during Trypanosoma cruzi infection. J Immunol 1991;46:3591-8.
11. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992;175:169-74.
12. Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 1991;146:3626-32.
13. Silva JS, Twardzik DR, Reed SG. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med 1991;174:539-45.
14. Hoft DF, Lynch RG, Kirchhoff LV. Kinetic analysis of antigenspecific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J Immunol 1993;151:7038-47.
15. Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, Morrissey PJ. IL-10 mediates susceptibility to Trypanosoma crizi infection. J Immunol 1994;153:3135-40.
16. Swoboda R, Bommhardt U, Schimpl A. Regulation of lymphokine expression in T cell activation. I. Rapid loss of interleukinspecific RNA after removal of the stimulating signal. Eur J Immunol 1991;21:1691-5.
17. Taliaferro WH, Pizzi T. Connective tissue reactions in normal and immunized mice to a reticulotropic strain of Trypanosoma cruzi. J Infect Dis 1955;96:199-226.
18. Litton MJ, Dohlsten M, Lando PA et al. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma. Eur J mmunol 1996;26:1-9.
19. Higuchi M, Gutierrez PS, Aiello VD et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 1993;423:157 60.
20. Marcovistz R, Decote RD, Goncalves da Costa SC. 2 5 A synthetase expression in mice infected with Trypanosoma cruzi. Pathol Biol (Paris) 1992;40:234-7.
21. + lymphocytes. Am J Trop Med Hyg 1993;48:637-44.
22. + cells and natural cytotoxic activity among spleen, blood, and heart lymphocytes during the acute phase of Trypanosoma cruzi infection in rats. Infect Immun 1992;60:1024-30.
23. + T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection, Am J Trop Med Hyg 1990;48:161-9.
24. + lymphocytes in inflammatory exudates. Rev Soc Bras Med Trop 1994;27:127-34.
25. +). Trans R Soc Trop Med Hyg 1988;82:84-9.
26. Ribeiro-dos-Santos R, Pirmez C, Savino W. Role of autoreaetive immunological mechanisms in chagasic carditis. Res Immunol 1991;142:134-7.
27. Müssener A, Litton MJ, Lindroos E, Klareskog L. Cytokine expression in synovial tissue of mice with collagen induced-arthritis. Submitted.
28. Cardillo F, Falcao RP, Rossi MA, Mengel J. An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection. Eur J Immunol 1993;23:2597-605.
29. Trischmann TM, Bloom BR. Genetics of murine resistance to Trypanosoma cruzi. Infect Immun 1982;35:546-51.
30. Cardoni RL, Antunez MI, Örn A, Grönvik K-O. T-cell receptor (TCR) Vb repertoire in the thymus and spleen of mice infected with Trypanosoma cruzi. Cell Immunol 1996;169:238-45.
31. Tarleton RL, Koller BH, Latour A, Postan M. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 1992;356:338-40.
32. Tarleton RL, Grusby MJ, Postan M, Glimcher, LH. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol 1996;8:13-22.
33. +, MHC restricted cytotoxic T-cells that lyse parasite infected target cells. J Immunol 1993;150:1446-57.
34. Rottenberg ME, Bakhiet M, Olsson T et al. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun 1993;61:5129-33.
35. Rottenberg ME, Riarte A, Sporrong L et al. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunol Lett 1995;45:53-60.
36. Plater-Zyberk C, Bonnefoy JY. Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nature Medicine 1995;1:781-5.
37. Petray P, Rottenberg ME, Grinstein S, Örn A. Release of nitricoxide during the experimental infection with Trypanosoma cruzi. Parasit Immunol 1994;16:193-9.
38. Petray P, Castanos-Velez E, Grinstein S, Örn A, Rottenberg ME. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol Lett 1995;47:121-6.
39. Rottenberg ME, Sporrong L, Persson I, Wigzell H, Örn A. Cytokine gene expression during infection of mice lacking CD4 and/or CDS with Trypanosoma cruzi. Scand J Immunol 1995;41:164-70.
40. Vespa GNR, Cunha FQ, Silva JS. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 1994;62:5177-82.
41. Zhang L, Tarleton R. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol 1996;26:102-9.
42. Hontebeyrie-Joskowicz M. Murine Trypanosoma cruzi infection: a role for TH2 cells in the immunopathology of chronic infection. Res Immunol 1991;142:141-3.
43. Hontebeyrie-Joskowicz M. Immunoregulatory mechanisms and Chagas' disease. Mem Inst Oswaldo Cruz Suppl 1992; 5:101-3.
44. + TH2 cell line isolated from mice chronically infected with Trypanosoma cruzi induces IgG2 polyclonal response in vivo. Eur J Immunol 1990;20:1045-51.
45. Truyens C, Angelo-Barrios A, Torrico F, Van Damme J, Heremans H, Carlier Y. Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses. Infect Immun 1994;62:692-6.
46. Tanowitz HB, Gumpretch JP, Spurr D et al. Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J Infect Dis 1992;166:598-603.
47. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
48. Nachmann RL, Hajjar KA, Silverstein RL, Dinarello CA. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med 1986;163:1595-600.
49. Molina HA, Kierszenbaum F. Immunohistochemical detection of deposits of eosinophil-derived neurotoxin and eosinophil peroxidase in the myocardium of patients with Chagas' disease. Immunol 1988;64:725-31.
50. Molina HA, Kierszenbaum F. Eosinophil activation in acute and chronic chagasic myocardial lesions and deposition of toxic eosinophil granule proteins on heart myofibers. J Parasitol 1989;75:129-33.
51. Cardillo F, Voltarelli JC, Reed SG, Silva JS. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 1996;64:128-34.
52. Lima S, Minoprio P. Chagas Disease is attenuated in mice lacking γδ T cells. Infect Immun 1996;64:1215-21.